BBLG

Bone Biologics
$0.39
−$0.00 (−1.02%)Oct 29, 2026
0.4PoorMoatMint rating

MoatMint rates Bone Biologics (BBLG) 0.4 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 1.1 out of 10.

Return-100.0%5YRange $0.37 - $6,206.46
$6951$4634$2317$0.0Nov 21Sep 25Oct 26

Key metrics

The numbers that frame BBLG today
Market cap
$1.31M
ROIC
18,808.6%
Div yield
0%
Debt / equity
0.0
52wk Low
$0.36
52wk High
$2.39

BBLG stock rating

How BBLG scores on quality, value, growth, momentum and financial health
0.4out of 10
Low overallNeutral business, valuation unclear
Quality1.1
Growth1.6
Momentum0.6
Value-
Financial Health1.0

Growth

Revenue and earnings trend for BBLG
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about BBLG
Is Bone Biologics a good buy?
No. Bone Biologics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case.
What is the market capitalization of BBLG?
Bone Biologics's market capitalization is $1.31M.
What is the 52-week high for BBLG stock?
The 52-week high for Bone Biologics is $2.39. The current close of $0.39 is 83.8% below that high.
What is the 52-week low for BBLG stock?
The 52-week low for Bone Biologics is $0.36. The current close of $0.39 is 7.5% above that low.
Does BBLG stock pay dividends?
Bone Biologics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for BBLG?
Bone Biologics's Debt / Equity ratio is 0.